Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA), for its API manufacturing plant at Srikakulam, Andhra Pradesh, indicating closure of the audit and the inspection classification of this facility is determined as Voluntary Action Indicated (VAI). With this, all facilities under warning letter are now determined as VAI.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
